Actinium Pharmaceuticals
ATNM
ATNM
38 hedge funds and large institutions have $9.37M invested in Actinium Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less capital invested
Capital invested by funds: $11.5M → $9.37M (-$2.12M)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Holders
38
Holding in Top 10
–
Calls
$5M
Puts
$1.3M
Top Buyers
| 1 | +$181K | |
| 2 | +$126K | |
| 3 | +$99K | |
| 4 |
William Blair & Company
Chicago,
Illinois
|
+$70K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$58.6K |
Top Sellers
| 1 | -$441K | |
| 2 | -$341K | |
| 3 | -$157K | |
| 4 |
DLG
Daniel L. Goodwin
|
-$60K |
| 5 |
Morgan Stanley
New York
|
-$51.8K |